News & Events

Christopher U. Missling (KSM '00)


7/8/2013 - Appointed CEO of Anavex Life Sciences Corp., a pharmaceutical company that recently entered into a $10 million financing commitment with Lincoln Park Capital, a Chicago-based institutional investor.